7-Hydroxyamoxapine

Chemical structure of 7-Hydroxyamoxapine

7-Hydroxyamoxapine is a metabolite of the tricyclic antidepressant amoxapine. It is formed in the body through the hydroxylation of amoxapine, primarily in the liver. This compound is of interest due to its potential pharmacological activity and its role in the overall therapeutic effects of amoxapine.

Pharmacology

7-Hydroxyamoxapine is known to contribute to the antidepressant effects of amoxapine. It acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), which means it inhibits the reuptake of the neurotransmitters serotonin and norepinephrine, increasing their levels in the synaptic cleft and enhancing neurotransmission. This action is believed to be a key mechanism in alleviating symptoms of depression.

Metabolism

Amoxapine is metabolized in the liver by the cytochrome P450 enzyme system. The primary metabolic pathway involves the hydroxylation of amoxapine to form 7-Hydroxyamoxapine. This process is crucial for the drug's pharmacokinetics and pharmacodynamics. The metabolite is further processed and eventually excreted from the body.

Clinical Significance

The presence of 7-Hydroxyamoxapine in the body can influence the efficacy and side effect profile of amoxapine. Understanding the metabolism and action of this metabolite helps in optimizing antidepressant therapy and managing potential side effects. It is important for clinicians to consider the role of active metabolites when prescribing and monitoring treatment with tricyclic antidepressants.

Related Compounds

7-Hydroxyamoxapine is related to other hydroxylated metabolites of tricyclic antidepressants, which often have distinct pharmacological properties. These metabolites can vary in their activity and contribute differently to the therapeutic and side effect profiles of their parent compounds.

Related Pages

• Amoxapine
• Tricyclic antidepressant
• Serotonin-norepinephrine reuptake inhibitor
• Metabolite